1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow BPDCN: new trials by email Literature Review of BPDCN trials Research Report on BPDCN
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CARCIK CD123/33 for Refractory/Relapsed AML and BPDCN in Children and Adults CARCIK CD123/33 infusion - AML (Acute Myeloid Leukemia), BPDCN | Phase 1 / Phase 2 | Recruiting | Fondazione Matilde Tettamanti Menotti De Marchi Onlus | 18 | 2026-10-01 | 2026-10-16 |
Blastic Plasmacytoid Dendritic Cell Neoplasm (1) · Leukemia, Myeloid, Acute (1)
Hematologic Diseases (1) · Hematologic Neoplasms (1) · Hemic and Lymphatic Diseases (1) · Histiocytic Disorders, Malignant (1) · Leukemia (1) · Leukemia, Myeloid (1) · Lymphoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin Neoplasms (1) · Skin and Connective Tissue Diseases (1)
Fondazione Matilde Tettamanti Menotti De Marchi Onlus (1)
Italy (1)
2025 (1)